Lomustine
CAS 13010-47-4 3 FDA-DMF suppliersSmall Molecule
Overview
Lomustine is an alkylating nitrosourea compound that has been used in chemotherapy. It is used primarily for the treatment of brain tumors and Hodgkin's disease.
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Lomustine expires — and exclusivity 18 May 2026. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Oncology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.